CN1278698C - Freeze dried injection of seeding of autumnal sowthistle-leaf ixeris and preparation method thereof - Google Patents
Freeze dried injection of seeding of autumnal sowthistle-leaf ixeris and preparation method thereof Download PDFInfo
- Publication number
- CN1278698C CN1278698C CN 200410083993 CN200410083993A CN1278698C CN 1278698 C CN1278698 C CN 1278698C CN 200410083993 CN200410083993 CN 200410083993 CN 200410083993 A CN200410083993 A CN 200410083993A CN 1278698 C CN1278698 C CN 1278698C
- Authority
- CN
- China
- Prior art keywords
- herba ixeritis
- sowthistle
- ixeritis sonchifoliae
- autumnal
- injection
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000007924 injection Substances 0.000 title claims abstract description 40
- 238000002347 injection Methods 0.000 title claims abstract description 40
- 241001412304 Ixeris Species 0.000 title claims abstract description 22
- 238000002360 preparation method Methods 0.000 title claims description 33
- 238000010899 nucleation Methods 0.000 title claims description 17
- 239000000284 extract Substances 0.000 claims abstract description 37
- 239000007788 liquid Substances 0.000 claims abstract description 19
- 238000000034 method Methods 0.000 claims abstract description 14
- 229920006122 polyamide resin Polymers 0.000 claims abstract description 13
- 238000000703 high-speed centrifugation Methods 0.000 claims abstract description 10
- 238000000108 ultra-filtration Methods 0.000 claims abstract description 10
- 239000000546 pharmaceutical excipient Substances 0.000 claims abstract description 9
- 239000000463 material Substances 0.000 claims abstract description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 124
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 35
- 239000003814 drug Substances 0.000 claims description 25
- 229940079593 drug Drugs 0.000 claims description 21
- 238000010828 elution Methods 0.000 claims description 17
- 230000006837 decompression Effects 0.000 claims description 16
- 238000001914 filtration Methods 0.000 claims description 16
- 238000004064 recycling Methods 0.000 claims description 16
- 238000000605 extraction Methods 0.000 claims description 12
- 229930003944 flavone Natural products 0.000 claims description 11
- 235000011949 flavones Nutrition 0.000 claims description 11
- 238000010521 absorption reaction Methods 0.000 claims description 9
- 239000012153 distilled water Substances 0.000 claims description 9
- 239000012567 medical material Substances 0.000 claims description 9
- 238000004321 preservation Methods 0.000 claims description 9
- 239000006228 supernatant Substances 0.000 claims description 9
- 239000012141 concentrate Substances 0.000 claims description 8
- 238000004108 freeze drying Methods 0.000 claims description 8
- 239000012982 microporous membrane Substances 0.000 claims description 8
- 239000000843 powder Substances 0.000 claims description 8
- 238000003756 stirring Methods 0.000 claims description 8
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 7
- 229930195725 Mannitol Natural products 0.000 claims description 7
- 239000000594 mannitol Substances 0.000 claims description 7
- 235000010355 mannitol Nutrition 0.000 claims description 7
- 229930091371 Fructose Natural products 0.000 claims description 4
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 4
- 239000005715 Fructose Substances 0.000 claims description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 3
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 claims description 3
- 150000002212 flavone derivatives Chemical class 0.000 claims description 3
- 239000008103 glucose Substances 0.000 claims description 3
- 239000008101 lactose Substances 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 3
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 claims description 3
- 229920001503 Glucan Polymers 0.000 claims description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 2
- TWNIBLMWSKIRAT-VFUOTHLCSA-N levoglucosan Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@H]2CO[C@@H]1O2 TWNIBLMWSKIRAT-VFUOTHLCSA-N 0.000 claims description 2
- 238000010298 pulverizing process Methods 0.000 claims 1
- 239000004615 ingredient Substances 0.000 abstract description 8
- 230000000144 pharmacologic effect Effects 0.000 abstract description 7
- 238000002474 experimental method Methods 0.000 abstract description 5
- 230000009471 action Effects 0.000 abstract description 4
- 238000000746 purification Methods 0.000 abstract description 2
- 229930003935 flavonoid Natural products 0.000 abstract 1
- 150000002215 flavonoids Chemical class 0.000 abstract 1
- 235000017173 flavonoids Nutrition 0.000 abstract 1
- 238000005259 measurement Methods 0.000 abstract 1
- 238000000926 separation method Methods 0.000 abstract 1
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 20
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 10
- 229960005305 adenosine Drugs 0.000 description 10
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 9
- 238000003556 assay Methods 0.000 description 9
- 210000004369 blood Anatomy 0.000 description 9
- 239000008280 blood Substances 0.000 description 9
- 150000002213 flavones Chemical class 0.000 description 8
- 230000000694 effects Effects 0.000 description 7
- 239000008176 lyophilized powder Substances 0.000 description 7
- 230000017531 blood circulation Effects 0.000 description 5
- 241000282472 Canis lupus familiaris Species 0.000 description 4
- 239000012535 impurity Substances 0.000 description 4
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 241000700159 Rattus Species 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 3
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 3
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 3
- 235000005493 rutin Nutrition 0.000 description 3
- 229960004555 rutoside Drugs 0.000 description 3
- 210000000115 thoracic cavity Anatomy 0.000 description 3
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 2
- 229930182837 (R)-adrenaline Natural products 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 241000700157 Rattus norvegicus Species 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 229960005139 epinephrine Drugs 0.000 description 2
- 229930182486 flavonoid glycoside Natural products 0.000 description 2
- 150000007955 flavonoid glycosides Chemical class 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- BNGXYYYYKUGPPF-UHFFFAOYSA-M (3-methylphenyl)methyl-triphenylphosphanium;chloride Chemical compound [Cl-].CC1=CC=CC(C[P+](C=2C=CC=CC=2)(C=2C=CC=CC=2)C=2C=CC=CC=2)=C1 BNGXYYYYKUGPPF-UHFFFAOYSA-M 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 1
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical class S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
- 206010014080 Ecchymosis Diseases 0.000 description 1
- 206010022086 Injection site pain Diseases 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- QGMRQYFBGABWDR-UHFFFAOYSA-M Pentobarbital sodium Chemical compound [Na+].CCCC(C)C1(CC)C(=O)NC(=O)[N-]C1=O QGMRQYFBGABWDR-UHFFFAOYSA-M 0.000 description 1
- 208000017442 Retinal disease Diseases 0.000 description 1
- 206010038923 Retinopathy Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 240000004460 Tanacetum coccineum Species 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 238000003795 desorption Methods 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 210000003191 femoral vein Anatomy 0.000 description 1
- 235000008384 feverfew Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 230000003601 intercostal effect Effects 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 229960002275 pentobarbital sodium Drugs 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 235000010288 sodium nitrite Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 210000003437 trachea Anatomy 0.000 description 1
- 238000002627 tracheal intubation Methods 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
Abstract
The present invention discloses a frozen dried injection of sowthistle-leaf ixeris seedling and a preparing method thereof. The frozen dried injection of sowthistle-leaf ixeris seedling is prepared from sowthistle-leaf ixeris seedling extracts and pharmaceutic adjuvants. Sowthistle-leaf ixeris seedling medicinal materials are extracted by an ultrasonic method, extract liquid is treated by high speed centrifugation and ultrafiltration, and polyamide resin poles are used for separation and purification to obtain the sowthistle-leaf ixeris seedling extracts, wherein the contents of total flavonoids which are main effective ingredients are larger than 40%. The results of content measurement and pharmacological experiments show that the injection comprises high contents of effective ingredients and has strong pharmacological actions.
Description
Affiliated technical field
The invention belongs to technical field of traditional Chinese medicine pharmacy, be specifically related to a kind of freeze dried injection of seeding of autumnal sowthistle-leaf ixeris and preparation method thereof.
Background technology
Herba Ixeritis Sonchifoliae has another name called Herba Ixeritis Sonchifoliae, is the living then dry herb of feverfew Herba Ixeritis Sonchifoliae.Nature and flavor hardship, suffering, flat, the tool heat-clearing and toxic substances removing, the effect of reducing swelling and alleviating pain, its main component are flavonoid glycoside composition and ribosidoadenine.Modern study proves that this medicine has effects such as coronary blood flow increasing, the circulation of improvement cardiac muscle to blood circulation, to the remarkable anticoagulant function of blood system energy, obviously increase the activity of fibrinoclase.The preparation that has gone on the market has KUDIEZI ZHUSHEYE (WS-10354 (ZD-0354)-2002), and KUDIEZI ZHUSHEYE has promoting blood circulation and stopping pain, heat clearing away blood stasis dispelling effect, is used for the thoracic obstruction of blood stasis impatency, and card is seen: the thoracic obstruction, pained, bitter taste, tongue is dark red or deposit ecchymosis etc.Be applicable to coronary heart disease, the angina pectoris person that sees the above-mentioned symptom.The person that also can be used for the cerebral infarction.Adopt decocting to boil among the KUDIEZI ZHUSHEYE preparation technology, the removal of impurity of stone mercaptans, this method extract water-solubility impurity is many, the technology more complicated, loss of effective components is big in the preparation process, thereby making the medicine active constituent content low, the injection inorganic salt content height of this method preparation easily produces pain during injection simultaneously.Injection is to the stability requirement height, carry, store, broken easily when transporting, also result in hand cramps.
Patent (application number 02109532) " a kind of treat cardiovascular and cerebrovascular vessel and retinopathy Chinese medicine and preparation method thereof " and patent (application number 03133969) " a kind of Herba Ixeritis Sonchifoliae pharmaceutical preparation and preparation method thereof " a kind of Herba Ixeritis Sonchifoliae injectable powder and preparation method are disclosed respectively, the former is a lyophilized injectable powder, the latter is for to make the powder pin with spray drying method, but these two invented technology method for makings have all been continued to use the preparation method of KUDIEZI ZHUSHEYE (WS-10354 (ZD-0354)-2002), no novelty substantially.
In data-searching, do not find the report of other relevant freeze dried injection of seeding of autumnal sowthistle-leaf ixeris.
Summary of the invention
The objective of the invention is to disclose a kind of active component content height, eutherapeutic Ixers sonchifolia freeze-dried powder preparation.
Another object of the present invention provides the preparation method of above-mentioned freeze-dried powder.
The present invention is achieved through the following technical solutions.
One, preparation method
(1) prescription of crude drug is: Herba Ixeritis Sonchifoliae.
(2) get the Herba Ixeritis Sonchifoliae medical material, pulverized the 20-50 mesh sieve, add 6-8 and doubly measure 70% ethanol, 20KHz frequency supersound extraction secondary, 30min for the first time, 20min for the second time, extracting liquid filtering merges, decompression recycling ethanol, Herba Ixeritis Sonchifoliae extractum.
(3) Herba Ixeritis Sonchifoliae extractum being added an amount of distilled water makes medicinal liquid contain 1g crude drug/ml, stir evenly, cold preservation is placed and is spent the night, and high speed centrifugation is got the supernatant ultrafiltration, polyamide resin column absorption on the ultrafiltrate, wash with water to effluent colourlessly, reuse 3-5 times of column volume amount 60%-80% ethanol elution merges ethanol elution, decompression recycling ethanol also concentrates, and obtains Herba Ixeritis Sonchifoliae extract.
(4) preparation prescription is: Herba Ixeritis Sonchifoliae extract 5-7 weight portion, pharmaceutic adjuvant 40-50 weight portion.
(5) get the said extracted thing and add the dissolving of injection water, filter, add pharmaceutic adjuvant, add the injection water, regulate pH value to 6.0-7.0 to ormal weight, filtering with microporous membrane, fill, lyophilization, promptly.
In the preparation of freeze dried injection of seeding of autumnal sowthistle-leaf ixeris, adopt ultrasonic method to extract effective ingredient, this technology is boiled with traditional decocting, alcohol reflux technology is compared, the extraction temperature is low, extraction time is short, because ultrasonic wave energy is destroyed the cell of vegetable drug, solvent is penetrated in the crude drug cell, thereby effective ingredient is dissolved in the solvent in the acceleration medical material, improves the extraction rate of effective ingredient.High speed centrifugation after the Herba Ixeritis Sonchifoliae extract cold preservation, the supernatant ultrafilter membrane ultrafiltration of molecular cut off 10000-30000, can effectively remove macromole impurity such as the contained matter of mixing of medicinal liquid, protein, resin, starch, polyamide resin column absorption on the ultrafiltrate, wash with water remove partial impurities after, use the ethanol elution desorption, merge eluent, obtain the total flavonoid glycoside constituents.This method can make that main effective ingredient content of total flavone is greater than 40% in the Herba Ixeritis Sonchifoliae extract behind the purification, and adenosine content has improved the content of effective ingredient greater than 0.07%.Medicine exists with solid state after making lyophilized powder, has improved stability of formulation.Pharmacological evaluation proves that lyophilized powder of the present invention has better pharmacological action
The granularity of Herba Ixeritis Sonchifoliae medicinal material coarse powder supersound extraction is preferably the 30-40 mesh sieve among the above preparation technology, and during the polyamide resin column eluting, the concentration of alcohol of eluting polyamide resin column is preferably 70-75%.
Two, assay analysis
1, content of total flavone is measured in the Herba Ixeritis Sonchifoliae preparation
1.1 instrument and reagent: day island proper Tianjin UV-3000A ultraviolet spectrophotometer.KUDIEZI ZHUSHEYE (Tonghua Huaxia Pharmaceutical Co., Ltd., specification 10ml/ props up); Herba Ixeritis Sonchifoliae dry powder injection of the present invention (Tianzhijiao Medication Development Co., Ltd., Guangdong's laboratory provides); Control substance of Rutin (Nat'l Pharmaceutical ﹠ Biological Products Control Institute); Ethanol, sodium nitrite, aluminum nitrate, sodium hydroxide reagent are analytical pure, and water is tri-distilled water (self-control).
1.2 experimental technique: the assay method with reference to KUDIEZI ZHUSHEYE (WS-10354 (ZD-0354)-2002) total flavones is measured, and the results are shown in Table 1.
Total flavones in table 1 preparation (in anhydrous rutin) assay
| Lot number | Content (mg/ props up) | |
| KUDIEZI ZHUSHEYE | Freeze dried injection of seeding of autumnal sowthistle-leaf ixeris of the present invention | |
| 1 2 3 | 7.2 6.9 7.5 | 24.3 23.8 22.1 |
2, the assay of adenosine in the Herba Ixeritis Sonchifoliae preparation
Content assaying method with reference to adenosine in KUDIEZI ZHUSHEYE (WS-10354 (ZD-0354)-2002) quality standard is measured, and the results are shown in Table 2.
The assay of adenosine in table 2 preparation
| Lot number | Content (mg/ props up) | |
| KUDIEZI ZHUSHEYE | Freeze dried injection of seeding of autumnal sowthistle-leaf ixeris of the present invention | |
| 1 2 3 | 0.031 0.032 0.029 | 0.045 0.043 0.042 |
Above assay presentation of results, total flavones in the freeze dried injection of seeding of autumnal sowthistle-leaf ixeris of the present invention and adenosine content are apparently higher than total flavones and the adenosine content of KUDIEZI ZHUSHEYE (WS-10354 (ZD-0354)-2002).Illustrate that preparation method of the present invention is more reasonable, science has more practicality more.
3, the assay of total flavones and adenosine in the extract
Determining instrument, method are the same.Extract 1 (extracting method by KUDIEZI ZHUSHEYE (WS-10354 (ZD-0354)-2002) makes); Extract 2 (by Herba Ixeritis Sonchifoliae lyophilized powder extract process preparation of the present invention); The results are shown in Table 3 and table 4.
Total flavones in table 3 extract (in anhydrous rutin) assay
| Batch | Content (%) | |
| Extract 1 | Extract 2 | |
| 1 2 3 | 10.2 11.0 10.5 | 42.1 42.5 41.7 |
Adenosine content is measured in table 4 extract
| Batch | Content (%) | |
| Extract 1 | Extract 2 | |
| 1 2 3 | 0.044 0.046 0.041 | 0.075 0.072 0.070 |
Above assay presentation of results, effective ingredient total flavones and adenosine content total flavones and the adenosine content in the KUDIEZI ZHUSHEYE extract (according to the method for making gained in (WS-10354 (ZD-0354)-2002)) in the extract that preparation method of the present invention obtains.Preparation method of the present invention science more rationally is described, has more practicality.
Four, pharmacology embodiment
Reagent; Normal saline (Tianzhijiao Medication Development Co., Ltd., Guangdong's laboratory provides)
KUDIEZI ZHUSHEYE (Tonghua Huaxia Pharmaceutical Co., Ltd.)
Freeze dried injection of seeding of autumnal sowthistle-leaf ixeris of the present invention (Tianzhijiao Medication Development Co., Ltd., Guangdong's laboratory provides).
1, to the influence of coronary flow
Animal: healthy hybrid dog, 18, male and female dual-purpose, body weight 12-15kg.
Experimental technique: 18 dogs are divided into 3 groups at random, every group 6, normal saline group dosage is 2ml/kg, and administration group dosage is 1.5g/kg, and dog is anaesthetized with 3% pentobarbital sodium (30mg/kg), right arm reclining is fixed on the operating-table, separate femoral vein, insert venous cannulation, slowly import normal saline through vein, in order to administration, separate trachea, insert tracheal intubation and connect the capable malleation artificial respiration of respirator, 22 times/min of frequency, the 4-5 intercostal is opened the thoracic cavity in the left side, expose heart, separate ramus descendens anterior arteriae coronariae sinistrae top, place electromagnetic flowmeter probe (internal diameter 2mm-3mm), measure the coronary flow of whenever fighting, experiment finishes to take out heart and weighs.After operation finished, animal was stablized 20min, measured the coronary flow of whenever fighting, and 30min after the administration measures the coronary flow of whenever fighting again, calculates coronary flow and rate of change by following formula:
Coronary flow (ml/min100g)=whenever coronary flow (ml) * heart rate/cardiac weight (g) * 100 of fighting
Before rate of change=(after the administration-administration before)/administration * 100%
Experimental result sees Table 4.
The influence of table 4 pair dog coronary flow
| Grouping | Coronary flow (ml/min100g) | ||
| Before the administration | After the administration | Rate of change (%) | |
| The normal saline Herba Ixeritis Sonchifoliae is penetrated liquid Herba Ixeritis Sonchifoliae lyophilized powder of the present invention | 51.4±9.8 47.5±10.9 * 50.1±9.2 *# | 51.5±11.3 50.9±15.4 * 55.2±9.9 *# | 0.3±4.8 7.8±6.5 * 9.5±7.0 *# |
With normal saline group ratio
*P＜0.01 and injection ratio
#P＜0.05
Experimental result shows: freeze dried injection of seeding of autumnal sowthistle-leaf ixeris of the present invention and KUDIEZI ZHUSHEYE be the remarkable coronary blood flow increasing of energy all, but the effect of freeze dried injection of seeding of autumnal sowthistle-leaf ixeris of the present invention is obviously strong than KUDIEZI ZHUSHEYE, illustrates: the pharmacological action of freeze dried injection of seeding of autumnal sowthistle-leaf ixeris of the present invention is better than KUDIEZI ZHUSHEYE.
2, to hemorheological influence
Animal: Wistar rat, 40, male and female half and half, body weight 250 ± 5g.
Experimental technique: get the Wistar rat, be divided into 4 groups at random, every group 10, normal saline group and matched group intraperitoneal injection of saline every day 10ml/kg, continuous 7 days, the 7th day subcutaneous injection 0.1% epinephrine 0.8mg/kg of model group, after 2 hours rat immersed in the frozen water 5 minutes, injecting epinephrine in 2 hours again stops eating after once, administration group successive administration 7 days, administration group dosage is 5g/kg, and the modeling broken end was got blood and measured hemorheology with the multi-functional blood viscosity instrument of 3-9 type computer as stated above in the 7th day, the results are shown in Table 5.
The hemorheological influence of table 5 pair rat " syndrome of blood stasis "
| Grouping | Coronary flow (ml/min.100g) | |||
| Whole blood contrast viscosity (height is cut) | Plasma viscosity | Relative viscosity | Erythrocyte aggregation index | |
| Normal saline model group KUDIEZI ZHUSHEYE Herba Ixeritis Sonchifoliae lyophilized powder of the present invention | 3.22±1.2 6.12±1.5* 4.05±1.4 # 3.75±1.0 #Δ | 1.25±0.9 2.95±1.3 * 1.75±1.0 # 1.42±1.1 #Δ | 2.85±1.0 5.0±1.3 * 3.78±1.2 # 3.09±1.4 #Δ | 18.52±1.9 27.2±2.2 * 21.3±2.0 # 19.0±1.8 #Δ |
With normal saline group ratio
*P＜0.01 is with model group group ratio
#P＜0.01 is with the KUDIEZI ZHUSHEYE ratio
ΔP＜0.05
The pharmacological results shows: KUDIEZI ZHUSHEYE and Herba Ixeritis Sonchifoliae lyophilized powder of the present invention are to the effect that all has clear improvement of " syndrome of blood stasis " hemorheology of rat, the proof Herba Ixeritis Sonchifoliae has definite blood circulation promoting and blood stasis dispelling, the effect of microcirculation improvement, Herba Ixeritis Sonchifoliae lyophilized powder wherein of the present invention has than the better pharmacological action of KUDIEZI ZHUSHEYE.
Six, preparation embodiment,
Embodiment 1:
(1) prescription of crude drug is: Herba Ixeritis Sonchifoliae 1000g.
(2) get the Herba Ixeritis Sonchifoliae medical material, pulverized 40 mesh sieves, add 7 times of amount 70% ethanol, 20KHz frequency supersound extraction secondary, 30min for the first time, 20min for the second time, extracting liquid filtering merges, decompression recycling ethanol, Herba Ixeritis Sonchifoliae extractum.
(3) Herba Ixeritis Sonchifoliae extractum being added an amount of distilled water makes medicinal liquid contain 1g crude drug/ml, stir evenly, cold preservation is placed and is spent the night, and high speed centrifugation is got the supernatant ultrafiltration, polyamide resin column absorption on the ultrafiltrate, wash with water to effluent colourlessly, 4 times of column volume amount 70% ethanol elutions of reuse merge 70% ethanol elution, decompression recycling ethanol also concentrates, and obtains Herba Ixeritis Sonchifoliae extract 6.0g.
(4) preparation prescription is: Herba Ixeritis Sonchifoliae extract 6.0g, mannitol 44g.、
(5) get the said extracted thing and add the dissolving of injection water, filter, add mannitol, add the injection water, regulate pH value to 6.0-7.0 to ormal weight, filtering with microporous membrane, fill, lyophilization, promptly.
Embodiment 2:
(1) prescription of crude drug is: Herba Ixeritis Sonchifoliae 1000g.
(2) get the Herba Ixeritis Sonchifoliae medical material, pulverized 30 mesh sieves, add 8 times of amount 70% ethanol, 20KHz frequency supersound extraction secondary, 30min for the first time, 20min for the second time, extracting liquid filtering merges, decompression recycling ethanol, Herba Ixeritis Sonchifoliae extractum.
(3) Herba Ixeritis Sonchifoliae extractum being added an amount of distilled water makes medicinal liquid contain 1g crude drug/ml, stir evenly, cold preservation is placed and is spent the night, and high speed centrifugation is got the supernatant ultrafiltration, polyamide resin column absorption on the ultrafiltrate, wash with water to effluent colourlessly, 5 times of column volume amount 75% ethanol elutions of reuse merge 75% ethanol elution, decompression recycling ethanol also concentrates, and obtains Herba Ixeritis Sonchifoliae extract 6.5g.
(4) preparation prescription: Herba Ixeritis Sonchifoliae extract 6.5g, glucose 25g, mannitol 20g.
(5) get the said extracted thing and add the dissolving of injection water, filter, add glucose, mannitol, add the injection water, regulate pH value to 6.0-7.0 to ormal weight, filtering with microporous membrane, fill, lyophilization, promptly.
Embodiment 3:
(1) prescription of crude drug is: Herba Ixeritis Sonchifoliae 800g.
(2) get the Herba Ixeritis Sonchifoliae medical material, pulverized 50 mesh sieves, add 6 times of amount 70% ethanol, 20KHz frequency supersound extraction secondary, 30min for the first time, 20min for the second time, extracting liquid filtering merges, decompression recycling ethanol, Herba Ixeritis Sonchifoliae extractum.
(3) Herba Ixeritis Sonchifoliae extractum being added an amount of distilled water makes medicinal liquid contain 1g crude drug/ml, stir evenly, cold preservation is placed and is spent the night, and high speed centrifugation is got the supernatant ultrafiltration, polyamide resin column absorption on the ultrafiltrate, wash with water to effluent colourlessly, 3 times of column volume amount 60% ethanol elutions of reuse merge ethanol elution, decompression recycling ethanol also concentrates, and obtains Herba Ixeritis Sonchifoliae extract 5.0g.
(4) preparation prescription: Herba Ixeritis Sonchifoliae extract 5.0g, Dextran 45 g.
(5) get the said extracted thing and add the dissolving of injection water, filter, add glucosan, add the injection water, regulate pH value to 6.0-7.0 to ormal weight, filtering with microporous membrane, fill, lyophilization, promptly.
Embodiment 4:
(1) prescription of crude drug is: Herba Ixeritis Sonchifoliae 1200g.
(2) get the Herba Ixeritis Sonchifoliae medical material, pulverized 20 mesh sieves, add 8 times of amount 70% ethanol, 20KHz frequency supersound extraction secondary, 30min for the first time, 20min for the second time, extracting liquid filtering merges, decompression recycling ethanol, Herba Ixeritis Sonchifoliae extractum.
(3) Herba Ixeritis Sonchifoliae extractum being added an amount of distilled water makes medicinal liquid contain 1g crude drug/ml, stir evenly, cold preservation is placed and is spent the night, and high speed centrifugation is got the supernatant ultrafiltration, polyamide resin column absorption on the ultrafiltrate, wash with water to effluent colourlessly, 5 times of column volume amount 60% ethanol elutions of reuse merge ethanol elution, decompression recycling ethanol also concentrates, and obtains Herba Ixeritis Sonchifoliae extract 7.0g.
(4) preparation prescription: Herba Ixeritis Sonchifoliae extract 7.0g, dextrorotation fructose 40g, lactose 10g.
(5) get the said extracted thing and add the dissolving of injection water, filter, add pharmaceutic adjuvant, add the injection water, regulate pH value to 6.0-7.0 to ormal weight, filtering with microporous membrane, fill, lyophilization, promptly.
Embodiment 5:
(1) prescription of crude drug is: Herba Ixeritis Sonchifoliae 900g.
(2) get the Herba Ixeritis Sonchifoliae medical material, pulverized 30 mesh sieves, add 6 times of amount 70% ethanol, 20KHz frequency supersound extraction secondary, 30min for the first time, 20min for the second time, extracting liquid filtering merges, decompression recycling ethanol, Herba Ixeritis Sonchifoliae extractum.
(3) Herba Ixeritis Sonchifoliae extractum being added an amount of distilled water makes medicinal liquid contain 1g crude drug/ml, stir evenly, cold preservation is placed and is spent the night, and high speed centrifugation is got the supernatant ultrafiltration, polyamide resin column absorption on the ultrafiltrate, wash with water to effluent colourlessly, 4 times of column volume amount 75% ethanol elutions of reuse merge ethanol elution, decompression recycling ethanol also concentrates, and obtains Herba Ixeritis Sonchifoliae extract 5.5g.
(4) preparation prescription: Herba Ixeritis Sonchifoliae extract 5.5g, mannitol 35g, dextrorotation fructose 10g.
(5) get the said extracted thing and add the dissolving of injection water, filter, add pharmaceutic adjuvant, add the injection water, regulate pH value to 6.0-7.0 to ormal weight, filtering with microporous membrane, fill, lyophilization, promptly.
Embodiment 6:
(1) prescription of crude drug is: Herba Ixeritis Sonchifoliae 1100g.
(2) get the Herba Ixeritis Sonchifoliae medical material, pulverized 40 mesh sieves, add 8 times of amount 70% ethanol, 20KHz frequency supersound extraction secondary, 30min for the first time, 20min for the second time, extracting liquid filtering merges, decompression recycling ethanol, Herba Ixeritis Sonchifoliae extractum.
(3) Herba Ixeritis Sonchifoliae extractum being added an amount of distilled water makes medicinal liquid contain 1g crude drug/ml, stir evenly, cold preservation is placed and is spent the night, and high speed centrifugation is got the supernatant ultrafiltration, polyamide resin column absorption on the ultrafiltrate, wash with water to effluent colourlessly, 3 times of column volume amount 80% ethanol elutions of reuse merge ethanol elution, decompression recycling ethanol also concentrates, and obtains Herba Ixeritis Sonchifoliae extract 6.4g.
(4) preparation prescription is: Herba Ixeritis Sonchifoliae extract 6.4g, mannitol 28g, lactose 15g.
(5) get the said extracted thing and add the dissolving of injection water, filter, add pharmaceutic adjuvant, add the injection water, regulate pH value to 6.0-7.0 to ormal weight, filtering with microporous membrane, fill, lyophilization, promptly.
Claims (5)
1, a kind of freeze dried injection of seeding of autumnal sowthistle-leaf ixeris, it is characterized in that it is to be made by Herba Ixeritis Sonchifoliae extract 5-7 weight portion and pharmaceutic adjuvant 40-50 weight portion, wherein content of total flavone is more than or equal to 40% in the Herba Ixeritis Sonchifoliae extract, and the extracting method of described Herba Ixeritis Sonchifoliae extract is:
(1) get the Herba Ixeritis Sonchifoliae medical material, pulverized the 20-50 mesh sieve, add 6-8 and doubly measure 70% ethanol, 20KHz frequency supersound extraction secondary, 30min for the first time, 20min for the second time, extracting liquid filtering merges, decompression recycling ethanol, Herba Ixeritis Sonchifoliae extractum;
(2) Herba Ixeritis Sonchifoliae extractum being added an amount of distilled water makes every milliliter of medicinal liquid contain the 1g crude drug, stir evenly, cold preservation is placed and is spent the night, and high speed centrifugation is got the supernatant ultrafiltration, polyamide resin column absorption on the ultrafiltrate, wash with water to effluent colourlessly, reuse 3-5 times of column volume amount 60%-80% ethanol elution merges ethanol elution, decompression recycling ethanol also concentrates, and obtains Herba Ixeritis Sonchifoliae extract.
2, freeze dried injection of seeding of autumnal sowthistle-leaf ixeris according to claim 1, wherein pharmaceutic adjuvant is one or both the mixture in mannitol, glucosan, glucose, fructose, dextrorotation fructose and the lactose.
3, freeze dried injection of seeding of autumnal sowthistle-leaf ixeris according to claim 1, wherein the Herba Ixeritis Sonchifoliae pulverizing medicinal materials becomes 30-40 order coarse powder.
4, freeze dried injection of seeding of autumnal sowthistle-leaf ixeris according to claim 1, wherein the concentration of alcohol of eluting polyamide resin column is 70%-75%.
5, freeze dried injection of seeding of autumnal sowthistle-leaf ixeris according to claim 1, its preparation method is: get Herba Ixeritis Sonchifoliae extract and add the dissolving of injection water, filter, add pharmaceutic adjuvant, add the injection water to ormal weight, regulate pH value to 6.0-7.0, filtering with microporous membrane, fill, lyophilization, promptly.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200410083993 CN1278698C (en) | 2004-10-15 | 2004-10-15 | Freeze dried injection of seeding of autumnal sowthistle-leaf ixeris and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200410083993 CN1278698C (en) | 2004-10-15 | 2004-10-15 | Freeze dried injection of seeding of autumnal sowthistle-leaf ixeris and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1634395A CN1634395A (en) | 2005-07-06 |
| CN1278698C true CN1278698C (en) | 2006-10-11 |
Family
ID=34847301
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200410083993 Expired - Fee Related CN1278698C (en) | 2004-10-15 | 2004-10-15 | Freeze dried injection of seeding of autumnal sowthistle-leaf ixeris and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1278698C (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102293805B (en) * | 2011-01-06 | 2013-04-17 | 沈阳双鼎制药有限公司 | Total phenolic acid of ixeris sonchifolia (Bunge) hance, and preparation method |
| CN108420842A (en) * | 2018-04-28 | 2018-08-21 | 通化师范学院 | A Kudie preparation with anti-gout effect |
-
2004
- 2004-10-15 CN CN 200410083993 patent/CN1278698C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1634395A (en) | 2005-07-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1270769C (en) | Cinobufotalin lyophilized powder for injection and its preparation method | |
| CN1278698C (en) | Freeze dried injection of seeding of autumnal sowthistle-leaf ixeris and preparation method thereof | |
| CN1285344C (en) | Method for preparing acanthopanax injectio | |
| CN1468860A (en) | Manyprickle acanthopanax general saponin extractive and its medicinal composition | |
| CN1486743A (en) | Chinese medicine injection and its production process | |
| CN1179662C (en) | Health food composition for liver | |
| CN1457780A (en) | Total alkaloid composition from plant and its pharmaceutical preparation | |
| CN1686377A (en) | Chuankezhi (pant treating) powder injection and its preparation method | |
| CN1150918C (en) | Medicine containing active components of Panax japonicum root and preparing process thereof | |
| CN1634241A (en) | Compound formulation of notoginseng for treating cardiovascular and cerebrovascular diseases and its preparing process | |
| CN1682971A (en) | Compound isatis root freeze-dried powder injection and its preparing method | |
| CN1283230C (en) | Freeze-dried girald daphne powder injection and its preparing method | |
| CN1903213A (en) | Traditional Chinese medicine preparation with functions of immunological regulation for anti-chemical damage | |
| CN1237984C (en) | Prepn. method of freezing-drying powder injection for anticancer made of Chinese herb medicines | |
| CN1286480C (en) | Oral disintegrants of composite salvia miltiorrhiza and their preparation | |
| CN1554335A (en) | Freeze-dried Danhong powder injection for injection and its preparing method | |
| CN100551404C (en) | Preparation, detection method and use of diuretic and swelling medicinal composition | |
| CN1698717A (en) | Chinese medicinal compound fat emulsion injection and its preparation method | |
| CN1559469A (en) | Prepn. method for freezing-drying powder injection for treating cardiovascular disease | |
| CN1799602A (en) | Qi-invigorating, yin-nourishing medicinal pills and preparation method thereof | |
| CN119424489A (en) | A kind of Yin-dried Poria cocos decoction piece and its application in preparing medicine for treating renal fibrosis | |
| CN101081240A (en) | Medicinal composition of oxymatrine and polysaccharide | |
| CN1899385A (en) | Process for preparing Chinese medicine compound injection for treating chronic renal failure and use | |
| CN1817356A (en) | Production of vermilion injection for treating cardiovascular disease | |
| CN1634246A (en) | Compound formulation of breviscapine and asarum herb for treating cardiovascular and cerebrovascular diseases and its preparing process |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |